Evidence map›Paper›PMID 28105079›Full record

ArticleEcancermedicalscience2016

Hepatocellular carcinoma in identical twins in Chile: case report.

Christian Caglevic, Shirley Silva, Mauricio Mahave, Javiera Torres, Christian Rolfo, Jorge Gallardo, Paula Carrasco

Open access · goldAbstract readCase Reports
In one paragraph

Article in Ecancermedicalscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Christian CaglevicUnit of Investigational Cancer Drugs, Instituto Oncologico Fundación Arturo López Pérez, Santiago, Chile; Instituto Oncològico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.
Shirley SilvaRadiation Oncology, University of Valparaíso, Valparaíso, Chile; Instituto Oncològico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.
Mauricio MahaveUnit of Investigational Cancer Drugs, Instituto Oncologico Fundación Arturo López Pérez, Santiago, Chile; Instituto Oncològico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.
Javiera TorresAnatomical Pathology, Pontificia Universidad Católica de Chile, Santiago, Chile; Instituto Oncològico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.
Christian RolfoEarly Drug Development Unit-Phase 1 Studies, University Hospital of Antwerp, Antwerp, Belgium; Instituto Oncològico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.
Jorge GallardoOncólogo Médico Clínica Las Condes, Santiago, Chile; Instituto Oncològico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.
Paula CarrascoRadiation Oncology, Clínica Alemana, Temuco, Chile; Instituto Oncològico Fundación Arturo López Pérez, Rancagua 878, Providencia Santiago, Chile.
Fundación Arturo López Pérez · CLClínica Alemana · CLClínica Las Condes · CLPontificia Universidad Católica de Chile · CLUniversity of Valparaíso · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver cancer is the second leading cause of cancer death worldwide, with hepatocellular carcinoma (HCC) being the most common type of primary malignant liver tumour, with a typically poor prognosis, growing incidence and a well-documented relationship with chronic inflammation factors of the liver tissue. Despite the fact that family medical history has been identified as a risk factor for the development of HCC, its significance in terms of etiopathogenesis and prognosis is not well documented. With a view to contributing to this discussion, we will report the clinical case of two identical twins with HCC, both diagnosed within a short period of time, by providing relevant clinical data, and relating this to other medical literature reports that could contribute to a deeper understanding of this illness.

Indexed as

brothersgeneticshepatocarcinoma (HCC)relativestwins

Identifiers

PMID28105079
PMCPMC5221639
OpenAlexW2564857518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.